Faecal Micro-RNAs in Inflammatory Bowel Diseases.

Area of Science:

• Gastroenterology
• Molecular Biology
• Biomarker Discovery

Background:

• Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), utilize faecal biomarkers to assess disease activity.
• Micro-RNAs (miRNAs) are small, non-coding RNAs found in extracellular fluids, offering potential as clinical biomarkers.

Purpose of the Study:

• To investigate alterations in faecal miRNA composition in patients with IBD.
• To identify specific miRNAs associated with IBD activity and differentiate them from other gastrointestinal conditions.

Main Methods:

• Quantification of over 800 human faecal miRNAs using NanoString technology in stool samples from controls and active CD patients.
• Validation of selected miRNAs (miR-223, miR-1246) via qRT-PCR in faeces, serum, and intestinal tissue across control, CD, UC, and Clostridium difficile infection (CDI) cohorts.

Main Results:

• 150 miRNAs were significantly detected in faeces; multivariate analysis revealed distinct miRNA profiles in active CD patients.
• Elevated levels of miR-223 and miR-1246 were observed in active UC patients compared to controls.
• Faecal miR-1246, but not miR-223, was higher in patients with CDI; no significant differences were found in serum samples.

Conclusions:

• This study presents the first comprehensive screen of faecal miRNAs in IBD.
• Findings suggest miR-223 and miR-1246 are potential biomarkers for IBD activity.
• Further research is needed to validate these findings and elucidate the biological roles of faecal miRNAs in IBD.